“…Kudryavtseva et al (2019) continued the search for new biologically active substances with effective antibacterial activity with a study of a series of N 9 ‐substituted acridine‐9‐amines, derivatives 16a–c (Figure 14). Earlier studies of acridone and acridine derivatives had found that the introduction of the methyl group to the acridine skeleton has a slight effect on antimicrobial activity (Kudryavtseva, Lamanov, Klimova, & Nazarov, 2018; Kudryavtseva, Sysoev, Popkov, & Klimova, 2017). The antimicrobial activity of the N ‐[2‐(2‐methyl‐5‐nitro‐1 H ‐imidazol‐1‐yl)ethyl]acridine‐9‐amine hydrochloride derivative 16a and the 2‐methoxy‐ N ‐[2‐(2‐methyl‐5‐nitro‐1 H ‐imidazol‐1‐yl)ethyl]acridine‐9‐amine hydrochloride derivative 16c was studied in vitro against test strains of E. coli , P. aeruginosa , P. vulgaris , S. aureus , B. subtilis , and Candida albicans microorganisms using the commonly used medications ethacridine lactate (rivanol) and metronidazole as a standard control.…”